Are you developing small molecule drugs? If so, you know that the preclinical phase of drug development is critical to the success of your program. Our contract research organization (CRO) has a proven track record of helping clients accelerate their preclinical work and bring their small molecule drugs to market quickly and efficiently.
We offer a comprehensive range of preclinical services, including:
- Target validation and identification
- Assay development and screening
- Lead optimization
- Preclinical toxicology
- Biodistribution and pharmacokinetics
- Drug metabolism and pharmacokinetics (DMPK)
- Safety pharmacology
Our team of experienced scientists and technicians has a deep understanding of small molecule drugs and the preclinical drug development process. We are committed to providing our clients with the highest quality services and support to help them achieve their drug development goals.
Small molecules: Defined as organic compounds with low molecular weight, small molecule drugs have been the mainstay of the pharmaceutical industry for almost a century. The rapid advancement of high-throughput screening, biopharmaceutical research, and technology opens up possibilities for innovative and creative new approaches to developing small molecule drugs.